Bioventix PLC (AIM:BVXP)
London · Delayed Price · Currency is GBP · Price in GBX 1,700.00
+25.00 (1.49%)
May 26, 2026, 4:35 PM GMT
Bioventix Market Cap
Bioventix has a market cap or net worth of 87.52 million as of May 26, 2026. Its market cap has decreased by -41.23% in one year.
Market Cap
87.52M
Enterprise Value
82.21M
Revenue
12.54M
Ranking
n/a
PE Ratio
11.92
Stock Price
1,700.00
Market Cap Chart
Since April 8, 2010, Bioventix's market cap has increased from 9.85M to 87.52M, an increase of 788.72%. That is a compound annual growth rate of 14.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 22, 2026 | 87.52M | -12.07% |
| Dec 31, 2025 | 99.53M | -39.94% |
| Dec 31, 2024 | 165.72M | -26.16% |
| Dec 29, 2023 | 224.45M | 7.98% |
| Dec 30, 2022 | 207.85M | 17.35% |
| Dec 31, 2021 | 177.12M | -22.46% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Scancell Holdings | 228.31M |
| Faron Pharmaceuticals Oy | 82.80M |
| Ondine Biomedical | 77.93M |
| 4basebio | 75.07M |
| hVIVO | 55.65M |
| Hemogenyx Pharmaceuticals | 46.92M |
| Poolbeg Pharma | 35.54M |
| Sareum Holdings | 28.41M |